FAQ

MONTANIDE ISA 720

Known as: ISA 720 
A proprietary adjuvant, applicable for water-in-oil (W/O; 30/70 v/v) vaccine emulsion, with potential immunoadjuvant activity. Montanide ISA 720 is… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1994-2017
0519942017

Related topics

Related topics

1 relation

Broader (1)

mannide monooleate

Related mentions per year

Related mentions per year

1966-2017
1960198020002020
MONTANIDE ISA 720
mannide monooleate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Phase I safety and immunogenicity trial of Plasmodium vivax CS derived long synthetic peptides adjuvanted with montanide ISA 720 or montanide ISA 51.
We assessed the safety, tolerability, and immunogenicity of a mixture of three synthetic peptides derived from the Plasmodium… (More)
Is this relevant?
2011
2011
A Phase 1 Trial of MSP2-C1, a Blood-Stage Malaria Vaccine Containing 2 Isoforms of MSP2 Formulated with Montanide® ISA 720
BACKGROUND In a previous Phase 1/2b malaria vaccine trial testing the 3D7 isoform of the malaria vaccine candidate Merozoite… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
2011
2011
Preclinical vaccine study of Plasmodium vivax circumsporozoite protein derived-synthetic polypeptides formulated in montanide ISA 720 and montanide ISA 51 adjuvants.
Plasmodium vivax circumsporozoite (CS) protein is a leading malaria vaccine candidate previously assessed in animals and humans… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
Is this relevant?
2008
2008
Safety and Immunogenicity of a Recombinant Plasmodium falciparum AMA1 Malaria Vaccine Adjuvanted with Alhydrogel™, Montanide ISA 720 or AS02
BACKGROUND Plasmodium falciparum Apical Membrane Antigen 1 (PfAMA1) is a candidate vaccine antigen expressed by merozoites and… (More)
Is this relevant?
2008
2008
Safety and Immunogenicity of a Malaria Vaccine, Plasmodium falciparum AMA-1/MSP-1 Chimeric Protein Formulated in Montanide ISA 720 in Healthy Adults
BACKGROUND The P. falciparum chimeric protein 2.9 (PfCP-2.9) consisting of the sequences of MSP1-19 and AMA-1 (III) is a malaria… (More)
  • figure 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
2005
2005
Montanide ISA 720 vaccines: quality control of emulsions, stability of formulated antigens, and comparative immunogenicity of vaccine formulations.
Montanide ISA 720 is an experimental adjuvant, formulated as water-in-oil emulsions, that induces high antibody titers in several… (More)
Is this relevant?
2005
2005
Safety and enhanced immunogenicity of a hepatitis B core particle Plasmodium falciparum malaria vaccine formulated in adjuvant Montanide ISA 720 in a phase I trial.
Highly purified subunit vaccines require potent adjuvants in order to elicit optimal immune responses. In a previous phase I… (More)
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Montanide ISA 720 and 51: a new generation of water in oil emulsions as adjuvants for human vaccines.
The development of adjuvants will represent a major challenge for this century. Indeed the need for safer vaccines leads to the… (More)
Is this relevant?
2001
2001
A phase I clinical trial of a multi-epitope polypeptide TAB9 combined with Montanide ISA 720 adjuvant in non-HIV-1 infected human volunteers.
A phase I clinical trial was performed to examine the safety and immunogenicity of a multi-epitope polypeptide comprising the… (More)
Is this relevant?
1997
1997
Phase I trial in humans of an oil-based adjuvant SEPPIC MONTANIDE ISA 720.
Seppic MONTANIDE ISA 720 is a metabolizable oil adjuvant that has given good results in animals with recombinant malarial… (More)
Is this relevant?